Levoketoconazole in the Treatment of Patients With Cushing ’s Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study

ConclusionsTreatment with levoketoconazole led to sustained normalization of mUFC and improvement in glycemic control that was more pronounced in patients with DM.Clinical Trial Registration(ClinicalTrials.gov), NCT01838551.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research